(Q34033174)

30 July 2017

1 reference

title

Bioactive CD4 ligands as pre- and/or postbinding inhibitors of HIV-1. (English)

1 reference

ORCID Public Data File 2021

30 July 2017

1 reference

author name string

Briant L

series ordinal

1

1 reference

30 July 2017

Devaux C

series ordinal

2

1 reference

30 July 2017

language of work or name

1 reference

1 January 2000

1 reference

30 July 2017

published in

Advances in Pharmacology

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

page(s)

373-407

1 reference

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Identification of the residues in human CD4 critical for the binding of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

HIV suppression by interleukin-16.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Transduction of Activation Signal That Follows HIV-1 Binding to CD4 and CD4 Dimerization Involves the Immunoglobulin CDR3-like Region in Domain 1 of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Improvement in AIDS patients on peptide T

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Interleukin 16 and its function as a CD4 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Design and synthesis of a highly immunogenic, discontinuous epitope of HIV-1 gp120 which binds to CD4+ve transfected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The Ick protein tyrosine kinase is not involved in antibody-mediated CD4 (CDR3-loop) signal transduction that inhibits HIV-1 transcription.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

HIV-1 auxiliary proteins: making connections in a dying cell

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Antibody-structure-based design of pharmacological agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Interaction between CD4 and class II MHC molecules mediates cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Structural and Functional Properties of HIV-1(GER) TAR Sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Identification of a human CD4-CDR3-like surface involved in CD4+ T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Review of GCDFP-15. An apocrine marker protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

HIV: a new role for Nef in the spread of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Myristoylation-dependent binding of HIV-1 Nef to CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56Ick in human CD4 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

gp160 of HIV or anti-CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Increased anti-HIV-1 activity of CD4 CDR3-related synthetic peptides by scrambling and further structural modifications, including D-isomerization and dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Antigenic analysis of HIV type 1 external envelope (Env) glycoprotein C2 region: implication for the structure of Env.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The structure of the CD4 and CD8 genes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Molecular Determinants of Nef Function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Regulation of T helper-B lymphocyte adhesion through CD4-HLA class II interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Structure-based design of immunologically active therapeutic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Blocking of HIV-1 infection, but not HIV-1-induced syncytium formation, by a CD4 peptide derivative partly corresponding to an immunoglobulin CDR3

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Monoclonal antibodies to a CD4 peptide derivative which includes the region corresponding to an immunoglobulin CDR3: evidence of the involvement of pre-CDR3-related region in HIV-1 and host cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Inhibition of HIV-1 replication by a monoclonal antibody directed toward the complementarity determining region 3-like domain of CD4 in CD45 expressing and CD45-deficient cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Characterization of the RNA dependent DNA polymerase of a new human T lymphotropic retrovirus (lymphadenopathy associated virus)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Monoclonal CD4 antibodies after accidental HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Nef-CD4 physical interaction sensed with the yeast two-hybrid system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Crystal structure of an HIV-binding recombinant fragment of human CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Epitopes of the CD4 antigen and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Primary structure of a new actin-binding protein from human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Phase II study of anti-CD4 idiotype vaccination in HIV positive volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

A novel gene of HIV-1, vpu, and its 16-kilodalton product

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the alpha-chain of the human interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Dimeric association and segmental variability in the structure of human CD4

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Human herpesvirus 7 infection of CD4+(+) T cells does not require expression of the OKT4 epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Processing and activation of pro-interleukin-16 by caspase-3

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2948012-9

7 January 2021

10.1016/S1054-3589(00)48012-9

Identifiers

DOI

1 reference

30 July 2017

1 reference